家禽用医薬品市場- 世界の産業規模、シェア、動向、機会、予測、種別、製品別、疾患別、流通チャネル別、地域別、競合別、2020-2030年

家禽用医薬品の世界市場規模は2024年に67億8,000万米ドルで、2030年には101億米ドルに達すると予測され、CAGRは6.84%です。

世界の家禽用医薬品市場は、食肉や卵などのタンパク質が豊富な食品に対する世界的な需要の高まりに対応するために、養鶏産業が重要な役割を果たし続けているため、着実に拡大しています。商業養鶏の成長と獣医学の進歩は、効果的な治療と予防ソリューションに対する強い需要を生み出しています。鳥インフルエンザ、ニューカッスル病、コクシジウム症などの家禽関連疾病の流行の高まりと相まって、動物の健康管理を改善する必要性がさらに市場を押し上げています。群れの生産性を維持し、死亡率を最小化するためにワクチン、医薬品、飼料添加物の採用が増加していることが、この分野への投資拡大を促しています。高品質な鶏肉製品に対する消費者の強い嗜好も、バイオセキュリティと高度なヘルスケア慣行への関心の高まりにつながっており、家禽用医薬品の成長を刺激しています。

主な成長要因のひとつは、先進国、発展途上国を問わず家禽肉の消費が急増していることです。このような消費量の増加は、家禽生産者に家禽群の健康維持という大きなプレッシャーを与え、予防薬や治療薬の需要を生み出しています。市場を形成する顕著な動向は、抗菌剤耐性に関する懸念から、プロバイオティクス、植物性添加物、ワクチンなど、抗生物質に代わる解決策へのシフトの増加です。診断と精密獣医療における技術の進歩も、疾病の早期発見と的を絞った治療を可能にし、家禽の健康管理の効率を高めています。勢いを増しているもうひとつの動向は、家禽の生産性を向上させ損失を減らすために、ワクチン接種、栄養補助食品、衛生習慣を組み合わせた総合衛生管理プログラムの採用です。

力強い成長の見通しにもかかわらず、市場は予測期間中にその可能性を抑制しかねない課題に直面しています。先進的な家禽用医薬品やワクチンに関連する高コストが、特に価格に敏感な経済圏の中小規模農家にとっては依然として障壁となっています。動物用医薬品、特に抗生物質の承認と使用に関する厳しい規制の枠組みも、メーカーにとってコンプライアンス上の課題となっています。抗菌剤耐性に対する懸念の高まりが規制の厳格化を促し、特定の従来型医薬品の採用に影響を与える可能性があります。さらに、手頃な価格と技術革新のバランスを維持することは、業界の利害関係者にとって引き続き重要な課題です。環境と食品の安全性への懸念に対処しながら、効果的な家禽用医薬品を広く利用できるようにすることは、世界家禽用医薬品市場の長期的な成長を維持するために引き続き重要です。

主な市場促進要因

家禽肉と卵の消費量の増加

主な市場課題

先進動物用医薬品の高コスト

主要市場動向

抗生物質フリーの家禽生産へのシフト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の家禽用医薬品市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 種別（鶏、トルコ、アヒル、その他）
  • 製品別（生物製剤、医薬品、薬用飼料添加物）
  • 病気別（ニューカッスル病、感染性気管支炎、感染性ファブリキウス嚢病、コクシジウム症、サルモネラ菌感染症、マレック病、その他）
  • 流通チャネル別（動物病院・クリニック、Eコマース、オフライン小売店、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の家禽用医薬品市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の家禽用医薬品市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の家禽用医薬品市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の家禽用医薬品市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの家禽用医薬品市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Calier S.A.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Kemin Industries, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Poultry Medicine Market was valued at USD 6.78 Billion in 2024 and is expected to reach USD 10.10 Billion by 2030 with a CAGR of 6.84%. The Global Poultry Medicine Market is witnessing steady expansion as the poultry industry continues to play a critical role in meeting the rising global demand for protein-rich food products such as meat and eggs. Growth in commercial poultry farming and advancements in veterinary medicine are creating strong demand for effective treatment and preventive solutions. The need for improved animal health management, coupled with the rising prevalence of poultry-related diseases such as avian influenza, Newcastle disease, and coccidiosis, is further boosting the market. Increasing adoption of vaccines, pharmaceuticals, and feed additives to maintain flock productivity and minimize mortality rates is encouraging greater investments in this segment. Strong consumer preference for high-quality poultry products is also leading to heightened focus on biosecurity and advanced healthcare practices, stimulating the growth of poultry medicine.

One of the major growth drivers is the surge in poultry meat consumption across both developed and developing nations, driven by its affordability and nutritional benefits. This rising consumption places significant pressure on poultry producers to maintain flock health, thus generating demand for preventive and therapeutic medicines. A prominent trend shaping the market is the increasing shift toward alternative solutions to antibiotics, such as probiotics, phytogenic additives, and vaccines, due to concerns around antimicrobial resistance. Technological advancements in diagnostics and precision veterinary medicine are also enabling early disease detection and targeted treatment, enhancing efficiency in poultry health management. Another trend gaining momentum is the adoption of integrated health management programs that combine vaccination, nutritional supplements, and hygiene practices to improve poultry productivity and reduce losses.

Despite strong growth prospects, the market faces challenges that could restrain its potential during the forecast period. High costs associated with advanced poultry medicines and vaccines remain a barrier, especially for small and medium-scale farmers in price-sensitive economies. Stringent regulatory frameworks concerning the approval and use of veterinary medicines, particularly antibiotics, also present compliance challenges for manufacturers. Rising concerns over antimicrobial resistance are prompting stricter controls, which may impact the adoption of certain conventional medicines. Moreover, maintaining the balance between affordability and innovation continues to be a key challenge for industry stakeholders. Ensuring widespread accessibility of effective poultry medicines while addressing environmental and food safety concerns will remain critical for sustaining long-term growth in the Global Poultry Medicine Market.

Key Market Drivers

Rising Poultry Meat and Egg Consumption

Rising poultry meat and egg consumption is a pivotal driver in the Global Poultry Medicine Market, as growing demand directly influences the adoption of advanced healthcare solutions for flocks. Poultry has become the most affordable and accessible source of animal protein, widely consumed due to its favorable nutritional profile, quick production cycle, and versatility in diets. Government statistics highlight the strength of this trend. In India, total egg production rose to 142.77 billion eggs in FY 2023-24, representing a 3.18% increase over the previous year, while poultry meat output reached 10.25 million tonnes, up by nearly 5% according to official data released by the Department of Animal Husbandry and Dairying. Per capita availability of eggs in India stood at 103 eggs per annum, which remains below the National Institute of Nutrition's recommendation, suggesting considerable growth potential in consumption.

Globally, the FAO-OECD Agricultural Outlook 2025-2034 projects poultry meat consumption to rise to 173 million tonnes (ready-to-cook basis) by 2034, accounting for about 62% of the total additional meat consumed worldwide. This growth reflects shifting dietary patterns as consumers in both developed and developing countries favor poultry over red meats due to affordability and health perceptions. In the United States, USDA data shows poultry remains a core component of the national diet, with per capita consumption consistently higher than beef and pork, reflecting strong cultural and nutritional preferences.

This steady rise in poultry meat and egg consumption underscores the need for effective disease prevention and treatment strategies. Producers must manage infectious risks while ensuring flock productivity and food safety. The growing reliance on veterinary medicines such as vaccines, biologics, and feed-based solutions is directly tied to this consumption boom, making rising demand for poultry products a crucial long-term growth driver for the market.

Key Market Challenges

High Cost of Advanced Veterinary Medicines

The high cost of advanced veterinary medicines represents one of the most significant challenges for the Global Poultry Medicine Market, particularly in regions where poultry farming is driven by small and medium-scale producers. Modern pharmaceuticals, biologics, and next-generation vaccines often involve extensive research, development, and regulatory approval processes, which substantially increase their market price. For commercial farms with large-scale operations, these costs may be manageable due to higher revenue streams, but for smaller producers, the financial burden becomes a barrier to adoption. Limited access to cost-effective alternatives leaves many farmers reliant on traditional or less effective solutions, increasing the risk of disease outbreaks, higher mortality, and reduced productivity.

The financial constraints also limit the ability of farmers to implement preventive healthcare programs, as they often prioritize immediate cost savings over long-term benefits. This creates a cycle were inadequate investment in quality medicines results in higher vulnerability to disease, leading to economic losses that could have been avoided with advanced treatments. The disparity in affordability also impacts market penetration for veterinary pharmaceutical companies, as demand for innovative products is concentrated in developed economies while adoption in emerging markets remains limited. Balancing innovation with affordability is a pressing challenge, as manufacturers must continue to invest in developing novel solutions to address issues like antimicrobial resistance and emerging poultry diseases, while ensuring that their products remain accessible to producers in price-sensitive regions. Without cost-effective strategies such as tiered pricing models, local manufacturing partnerships, or government-supported subsidies, the high cost of advanced veterinary medicines may slow down the widespread adoption of innovative healthcare practices in poultry farming, ultimately restricting the market's long-term growth potential.

Key Market Trends

Shift Toward Antibiotic-Free Poultry Production

The Global Poultry Medicine Market is experiencing a significant transformation driven by the industry-wide shift toward antibiotic-free poultry production. Growing concerns about antimicrobial resistance (AMR) and the presence of antibiotic residues in meat and eggs have prompted regulators, consumers, and producers to rethink their approach to poultry health management. Consumers are increasingly demanding clean-label, residue-free poultry products, compelling producers to seek alternatives that maintain bird health without compromising food safety. Governments across several regions have introduced stricter policies restricting the use of growth-promoting antibiotics in poultry farming, creating a strong push toward sustainable and responsible practices. This shift has created rising demand for probiotic formulations, phytogenic feed additives, vaccines, and herbal medicines, which offer effective disease prevention and immunity enhancement while aligning with consumer preferences.

Producers are also investing in improved biosecurity measures, nutritional optimization, and flock management strategies to reduce reliance on antibiotics. The market is witnessing increased innovation in natural and biologic-based solutions that address respiratory, digestive, and immunological challenges without contributing to AMR. Veterinary pharmaceutical companies are expanding research collaborations to develop next-generation alternatives that can be scaled effectively for commercial poultry operations. The trend toward antibiotic-free production is not only reshaping product portfolios but is also emerging as a competitive differentiator in the global poultry industry.

Key Market Players

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Calier S.A.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Kemin Industries, Inc.

Report Scope:

In this report, the Global Poultry Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Medicine Market, By Species:

• Chicken
• Turkey
• Ducks
• Others

Poultry Medicine Market, By Product:

• Biologics
• Pharmaceuticals
• Medicated Feed Additives

Poultry Medicine Market, By Disease:

• Newcastle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Coccidiosis
• Salmonella
• Marek's Disease
• Others

Poultry Medicine Market, By Distribution Channel:

• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others

Poultry Medicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Medicine Market.

Available Customizations:

Global Poultry Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Poultry Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Species (Chicken, Turkey, Ducks, Others)
  • 5.2.2. By Product (Biologics, Pharmaceuticals, Medicated Feed Additives)
  • 5.2.3. By Disease (Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, Coccidiosis, Salmonella, Marek's Disease, Others)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Offline Retail Stores, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Poultry Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Species
  • 6.2.2. By Product
  • 6.2.3. By Disease
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Poultry Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Species
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Disease
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Mexico Poultry Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Species
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Disease
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Canada Poultry Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Species
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Disease
      • 6.3.3.2.4. By Distribution Channel

7. Europe Poultry Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Species
  • 7.2.2. By Product
  • 7.2.3. By Disease
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Poultry Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Species
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Disease
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Poultry Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Species
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Disease
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Poultry Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Species
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Disease
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Poultry Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Species
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Disease
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Poultry Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Species
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Disease
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Poultry Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Species
  • 8.2.2. By Product
  • 8.2.3. By Disease
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Poultry Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Species
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Disease
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Poultry Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Species
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Disease
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. South Korea Poultry Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Species
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Disease
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Japan Poultry Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Species
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Disease
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Poultry Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Species
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Disease
      • 8.3.5.2.4. By Distribution Channel

9. South America Poultry Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Species
  • 9.2.2. By Product
  • 9.2.3. By Disease
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Poultry Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Species
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Disease
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Poultry Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Species
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Disease
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Poultry Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Species
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Disease
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Poultry Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Species
  • 10.2.2. By Product
  • 10.2.3. By Disease
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Poultry Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Species
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Disease
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Poultry Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Species
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Disease
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Poultry Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Species
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Disease
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Zoetis Services LLC
• 15.3. Vaxxinova International BV
• 15.4. Merck & Co., Inc.
• 15.5. Calier S.A.
• 15.6. Elanco Animal Health Incorporated
• 15.7. Hester Biosciences Limited
• 15.8. Ceva Sante Animale
• 15.9. Phibro Animal Health Corporation
• 15.10. Kemin Industries, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer